Sparing leukemia patients from unnecessary chemo
July 29, 2008 — NEW YORK (Reuters Health) - Nearly one-third of leukemia patients do not respond to chemotherapy, but this is not typically discovered until they have already endured a week-long course of chemotherapy and waited even longer to see if the chemotherapy worked.
Nexavar shows promise in acute myeloid leukemia
January 30, 2008 — CHICAGO (Reuters) - The kidney cancer pill Nexava, know generically as sorafenib, has shown promise in treating a small number of people with a type of blood cancer known as acute myeloid leukemia, or AML, U.S. researchers said on Tuesday.
Leukemia in Down's kids linked to parental factors
December 20, 2007 — NEW YORK (Reuters Health) - There appears to be a relationship between infertility or infertility treatments in the parents and a risk of developing acute leukemia in children with Down's syndrome, researchers report.
Select news items provided by Reuters Health